Skip to main content

Table 1 Characteristic of study participants at inclusion by randomization group

From: Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes

Characteristics

SP3 group

(n = 649)

SP2 group

(n = 625)

Study location

  

   Karaba village (n, %)

152 (23.42)

173(27.68)

   Koho village (n, %)

497 (76.58)

452(72.32)

Education

  

   none (n, %)

576 (90.85)

528(86.70)

   primary (n, %)

45 (7.10)

66 (10.84)

   secondary and higher (n, %)

13 (2.05)

15 (2.46)

Ethnicity

  

   bwaba (n, %)

160 (24.65)

165 (26.40)

   mossi (n, %)

423 (65.18)

400 (64.00)

   peuhl (n, %)

37 (5.70)

41 (6.56)

   other (n, %)

29 (4.47)

19 (3.04)

Occupation

  

   farmer/housewife (n, %)

625(96.30)

609 (97.44)

   student (n, %)

2 (0.31)

6 (0.96)

   other (n, %)

4 (0.62)

5 (0.80)

   missing (n, %)

18 (2.77)

5 (0.80)

Parity

  

   primigravidae (n, %)

130 (20.03)

135 (21.60)

   secundigravidae (n, %)

143 (22.03)

119 (19.04)

   multigravidae (n, %)

376 (57.94)

371 (59.36)

Gestation at enrolment

  

   first trimester (n, %)

263 (40.52)

235 (37.60)

   second trimester (n, %)

345 (53.16)

343 (54.88)

   third trimester (n, %)

41 (6.32)

47 (7.52)

Age

  

   mean (years) (95% CI)

24.26 (23.80-24.73)

24.66 (24.15-25.17)

Weight

  

   mean (kg) (95% CI]

55.40 (54.86-55.94)

55.36 (54.82-55.92)

Height

  

   mean (cm) (95% CI]

162.77 (162.32-163.25)

162.50 (162.04-162.96)

BMI at enrolment

  

   mean (95% CI]

20.88 (20.72-21.04)

20.95 (20.77-21.13)

Prevalence of peripheral infection

114 (17.57%)

123 (19.68%)